New Trifecta Study Publication: Prospera dd-cfDNA upheld as a leading indicator for kidney transplant rejection
Satellite Symposium sponsored by Natera
Watch Video
Satellite Symposium sponsored by Natera
Watch Video
Read More
Read More
Dive into the latest data showcasing the Prospera™ test as a proven leading indicator of rejection - a critical component to any transplant care team's rejection monitoring toolkit.
Watch Video
Halloran, et al. Transplantation 2023
Read More
Watch Video
Watch Video
Read More
Rosenheck JP, Keller BC, Fehringer G, et al. Curr Pulmonol Rep. 2022
Read More
Altug Y, Demko ZP, Ryan A. Letter to the Editors - Transplantation. 2020
Read More
Bunnapradist S, Homkrailas P, Ahmed E, et al. J Am Soc Nephrol 2021
Read More
Lum EL, Nieves-Borrero K, Homkrailas P, et al. Transplantation Reports. 2021
Read More
Qazi Y, Patel A, Fajardo M, et al. Transplant Proc. 2021
Read More
Chaperon JL, Wemmer NM, McKanna TA, et al. Am J Nephrol 2021
Read More
Ventura-Aguiar P, Ramirez-Bajo MJ, Rovira J, et al. Transplantation. 2022
Read More
Mrug M, Bloom MS, Seto C, et al. Kidney Medicine (2021)
Read More
Tantisattamo E, Reddy UG, Ichii H, et al. Nephron 2021
Read More
Cocorpus J, Hager MM, Benchimol C, et al. BMC Nephrol. 2022
Read More
Singh G, Gohh R, Clark D, et al. Genes. 2022
Read More
Halloran PF, Reeve J, Madill-Thomsen KS, et al. J Am Soc Nephrol.
Read More
Loading More...